Next, in Section 4, we point out existing mathematical models related to the dynamics of HER2+ BC and immune checkpoint inhibitors; then, we provide a general mathematical model that can be used to develop related specific models, and finally, we list some of the research gaps in this area. Here, ERBB2 is linked to breast cancer.